Suppr超能文献

长期服用度洛西汀对大鼠5-羟色胺能和去甲肾上腺素能系统影响的电生理特性研究

Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.

作者信息

Rueter L E, De Montigny C, Blier P

机构信息

Department of Psychiatry, McGill University, Montreal, Quebec, Canada.

出版信息

J Pharmacol Exp Ther. 1998 May;285(2):404-12.

PMID:9580577
Abstract

Duloxetine is a dual serotonin (5-HT)/norepinephrine (NE) re-uptake blocker with antidepressant potential. In the present in vivo electrophysiological study, the changes in the function of the rat 5-HT and NE systems after 2- and 21-day administration of duloxetine (20 mg/kg/day) were assessed in the dorsal hippocampus and the dorsal raphe nucleus (DRN). The firing rate of DRN neurons was decreased after 2 days of duloxetine, but returned to the control level after 21-day administration. This recovery of firing rate was presumably due to the desensitization of the DRN somatodendritic 5-HT1A autoreceptors found after long-term duloxetine administration. Overall serotonergic tone was assessed by examining the ability of the 5-HT1A antagonist WAY 100635 to alter hippocampal firing. WAY 100635 increased hippocampal firing rates in 21-day treated rats to a greater extent than in 2-day treated or control rats, suggesting that long-term administration induced an increase in endogenous levels of 5-HT in postsynaptic regions. This increase in 5-HT levels was accompanied by selective changes in the 5-HT and NE systems induced by long-term duloxetine administration, i.e., the desensitization of the alpha-2 adrenergic heteroreceptor on 5-HT terminals and the continued blockade of the 5-HT transporters. In contrast, the sensitivity of the alpha-2 adrenergic and terminal 5-HT1B autoreceptors, as well as that of the postsynaptic 5-HT1A receptor after 21-day treatment was unchanged. Therefore, this study demonstrates that duloxetine increases serotonergic tone in a limbic forebrain structure and may therefore be effective in the treatment of depression.

摘要

度洛西汀是一种具有抗抑郁潜力的5-羟色胺(5-HT)/去甲肾上腺素(NE)双重再摄取阻滞剂。在目前的体内电生理研究中,评估了度洛西汀(20mg/kg/天)给药2天和21天后大鼠背侧海马体和中缝背核(DRN)中5-HT和NE系统功能的变化。度洛西汀给药2天后DRN神经元的放电频率降低,但给药21天后恢复到对照水平。这种放电频率的恢复可能是由于长期给予度洛西汀后发现DRN躯体树突5-HT1A自身受体脱敏。通过检查5-HT1A拮抗剂WAY 100635改变海马体放电的能力来评估整体血清素能张力。WAY 100635使21天治疗组大鼠的海马体放电频率增加的程度大于2天治疗组或对照组大鼠,这表明长期给药会导致突触后区域内源性5-HT水平升高。5-HT水平的这种升高伴随着长期给予度洛西汀诱导的5-HT和NE系统的选择性变化,即5-HT终末上α-2肾上腺素能异受体的脱敏和5-HT转运体的持续阻断。相比之下,21天治疗后α-2肾上腺素能和终末5-HT1B自身受体以及突触后5-HT1A受体的敏感性没有变化。因此,本研究表明度洛西汀可增加边缘前脑结构中的血清素能张力,因此可能对抑郁症治疗有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验